Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Surgical treatment for idiopathic rhinitis using nerve procedures

Official title: Assessment of the Effectiveness and Safety of Posterior Nasal Nerve Combined With Anterior Ethmoid Neurotomy in Patients With Idiopathic Rhinitis: a Prospective, Multicentre, Parallel-controlled Study

Run by Renmin Hospital of Wuhan University · NCT06870292 · Data updated 2026-11-12

This study tests if a new type of surgery can help people with idiopathic rhinitis feel better than just using regular medication.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorRenmin Hospital of Wuhan University
Academic / other
Locations2 sites (Wuhan, Hubei and 1 other locations)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedOctober 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT06870292 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are nonsmoking adults aged 18 to 65 with a diagnosis of idiopathic rhinitis and specific symptom criteria.

Probably not a fit

Patients with other forms of chronic rhinitis or nasal conditions such as polyps or chronic sinusitis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a surgical approach combining posterior nasal nerve neurotomy with anterior ethmoid neurotomy for patients suffering from idiopathic rhinitis. Participants are randomized into two groups: one receiving the surgical intervention and the other receiving conventional drug therapy. The study includes a 7-day introductory period with nasal spray treatment before randomization, followed by a one-year follow-up to assess outcomes. The goal is to determine if the surgical method provides better relief from symptoms compared to medication alone.

Why it matters

Potential benefit: If successful, this approach could offer a more effective long-term solution for patients with idiopathic rhinitis who do not respond well to medication.

How similar studies have gone: While similar surgical approaches have been explored, this specific combination of techniques for idiopathic rhinitis is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients signed the free and informed consent form and understood the explanation of the study.
2. patients with IR between 18 and 65 years and their body mass index (BMI) should be ≥19 kg/m2 and ≤24 kg/m2.
3. Patients diagnosed with idiopathic rhinitis (IR)that were defined as nonsmoking patients with at least 2 nasal complaints of nasal obstruction, rhinorrhea, itching, and/or sneezing for more than 1 hour a day and for more than 1 year.
4. Patients with negative skin prick test (SPT) responses or sIgE
5. Nasal cytological exam with eosinophilia less than 20%.
6. Patients had a Total Nasal Symptom Score (TNSS) of ≥6 and a subscore of nasal discharge ≥2 and a subscore of nasal congestion ≥1.

Exclusion Criteria:

1. Patients with colored secretions, inflammation,nasal polyps, chronic sinusitis, nasal tumours.
2. Patients with other chronic rhinitis such as occupational rhinitis, drug rhinitis, gustatory rhinitis, hormonal rhinitis, atrophic rhinitis, etc.
3. Patients with anatomic nasal abnormalities responsible for nasal symptoms.
4. Patients with nasal/sinus surgery 3 months before the study.
5. Patients with severe mental illness.
6. Patients with uncontrolled asthma, systemic disorders or malignancies.
7. Patients with history of chronic smoking, substance abuse, drug use, and/or excessive alcohol consumption.
8. Patients in pregnancy or lactation.

Where it's running

  • Renmin Hospital of Wuhan University
    Wuhan, Hubei, China
    Recruiting
  • Renmin Hospital of Wuhan University
    Wuhan, Hubei, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.